(2-Ethoxy-4-(trifluoromethyl)phenyl)boronic acid, 95.0%, 250mg

1-(4-bromobenzyl)piperidine hydrochloride, 95.0%, 1g

(R)-5-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-3,4-dihydroxyfuran-2(5H)-one, 95.0%, 100g

5-Bromo-2-chloro-N-isopropylaniline, 95%, 10g

Benzopurpurine 4B5g

ethyl 6-(3-bromophenyl)-6-oxohexanoate, 97.0%, 1g

2-Naphthyl Laurate>98.0%(GC)5g

Methyl 5-nitro-1H-pyrazole-3-carboxylate, 95.0%, 5g

Methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate, 95.0%, 5g

4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-amine, 97%, 250mg

Screw top vials ROTILABO® ND8, Clear glass, with labelling space, 1.5 ml, 100 Piece(s)

4,7-Dichloro-1,6-naphthyridine, 95.0%, 100mg

3-[4-butyl-3-(4-chlorophenyl)-5-sulfanylidene-4,5-dihydro-1h-1,2,4-triazol-1-yl]propanoic acid, 97%, 100mg